)
)
Edge16 Oct 2026
Winner, Winner: The Chicken McNugget Story
How a 1940s breeding contest, a Cornell food scientist, and a hedge by Ray Dalio helped McDonald's turn the Chicken McNugget into a fast-food icon.
AtaiBeckley
AtaiBeckley (ATAI) investor relations material
AtaiBeckley EGM 2026 summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.EGM 2026 summary8 Sep, 2026
Opening remarks and agenda
CEO welcomed shareholders and introduced board, executive team, and advisors.
Meeting chaired in accordance with Delaware law; secretary and Inspector of Elections introduced.
Agenda, meeting rules, and notice of meeting made available via virtual portal.
Specific resolutions to be voted on
Proposal 1: Approve merger agreement with Eli Lilly and Company and Albali Acquisition Corporation.
Proposal 2: Approve adjournment of the meeting if more time is needed to solicit proxies.
Corporate governance
Quorum confirmed; meeting properly convened.
Inspector of Elections appointed and sworn in to certify voting results.
Voting conducted by proxy and online, with clear instructions for changing or submitting votes.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from AtaiBeckley
- Definitive merger with Eli Lilly announced; Q2 net loss $32.5M, cash $168.8M, key trials advancing.ATAI
Q2 2026 - Shareholders to vote on a merger with Eli Lilly for $6.75 per share plus up to $2.50 in CVRs.ATAIProxy filing
- Shareholders to vote on a $6.75 per share cash merger with Eli Lilly plus CVR up to $2.50.ATAIProxy filing
- Shareholders to vote on a merger offering up to $9.25 per share, closing expected Q3 2026.ATAIProxy filing
- Shareholders to vote on acquisition by Eli Lilly, advancing novel mental health therapies.ATAIProxy filing
- Shareholders will vote on a proposed acquisition by Eli Lilly, expected to close in Q3 2026.ATAIProxy filing
- Shareholders will vote on AtaiBeckley's acquisition by Eli Lilly, with clinical programs unaffected.ATAIProxy filing
- Shareholders will vote on a proposed acquisition by Eli Lilly, with closing expected in Q3 2026.ATAIProxy filing
- Definitive acquisition agreement with Eli Lilly targets Q3 2026 closing, pending approvals.ATAIProxy filing
Next AtaiBeckley earnings date
Q3 202620 Nov, 2026
AtaiBeckley
Next AtaiBeckley earnings date
Q3 202620 Nov, 2026
AI chat
Ask anything. Verify everything.
Ask across every event and document from public companies. Each answer links back to the exact line in the transcript, slide or filing it came from.Learn moreFind what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.)
Trust every finding
50m+ first-party documents. Every output traceable to its source.Find what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.Trust every finding
50m+ first-party documents. Every output traceable to its source.Automations
Zero in on what matters
Define the prompt once. It runs the moment a company publishes or on a schedule you set. Outputs map to the exact signals you choose.Learn more)
Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.)
Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Live audio & transcripts
Be first
Join any earnings call live in one click, with no manual registration. Follow the transcript as it happens and jump straight to the moments that matter.Learn more)
Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.)
Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Quartr MCP connects your AI environment to 17K+ public companies
Pull live transcripts, filings, and slides into Claude or Codex via MCP. Combine Quartr's global IR data with any other dataset. Run agentic research and monitoring.
Included with Quartr Pro at no extra cost.Learn more
Quartr's AI stands out because it only pulls clean, first-party data from public companies. In investing, that's everything.
Jamie Ross
Investment Manager, GAM Investments
GAM
GAM
Research that used to take hours now takes seconds with Quartr Pro. Tracking shifts in tone or extracting tables, it's as simple as typing a query.
Tom O'Hara
Investment Director
Ciena
Ciena
Before Quartr we spent hours manually compiling insights through the peer earnings cycle. Now, these tasks are done faster, with greater precision.
Gregg Lampf
VP of Investor Relations
Protean
Protean
Being able to ask specific questions across years of transcripts and reports and instantly get verified answers is a game-changer.
Pontus Dackmo
CEO & Investment Manager
)
)
Frequently asked questions
Atai Life Sciences N.V. is a clinical-stage biopharmaceutical company focusing on the acquisition, incubation, and development of therapeutics aimed at treating a range of mental health disorders such as depression, anxiety, addiction, among others. The company is developing a decentralized platform approach to expedite the development of effective mental health treatments. The company is headquartered in Berlin, Germany, and its shares are listed on the NASDAQ.